Business Wire

TX-GRC

13.2.2020 15:07:11 CET | Business Wire | Press release

Share
GRC Provides Liquid Immersion-Cooling Systems for Serbia’s First Green Data Center

GRC (Green Revolution Cooling), the leader in single-phase immersion cooling for data centers , today announced a new business collaboration with HiTeam, a subsidiary of E-Smart Systems, at the new ZELENDATA CENTRE in Technology Park in Vršac, Serbia, the country’s first green data center.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200213005508/en/

ZELENDATA CENTRE provides colocation, infrastructure as a service, and software as a service, and its Supermicro® servers are being cooled by GRC’s ICEraQ™ liquid immersion cooling systems.

“Our goal is to provide infrastructure with lower operating costs, as well as being environmentally conscious,” said Goran Veljović, Sales and Marketing Director at E-Smart Systems. “Using the ICEraQ immersion cooling system provides critical services today and will meet the needs of future data center users, while enabling companies to be environmentally responsible in their choice of data center provider. As the first green data center in Serbia, we are excited for the ZELENDATA CENTRE to lead the way, enabling Serbians to embrace business performance using green technologies.”

One of the main motivators for using GRC liquid-immersion cooling was the need to protect the environment in a cost-effective way. Additionally, the data center will realize a lower initial cost, as well as a significant savings in the Total Cost of Ownership (TCO), when compared to a traditional air-cooled data center. The main source of electricity for the data center is the MK Fintel Winds’ Košava wind farm in Izbiste. GRC’s immersion-cooling solution reduces electricity consumption of the cooling system at ZELENDATA CENTRE by 90%, or approximately 40% of the total consumption of the data center.

"We are thrilled to partner with E-Smart Systems to offer our ICEraQ Quad immersion cooling systems to the southeastern Europe market,” said Peter Poulin, CEO at GRC. “They are dedicated to protecting the environment, using green ‘environmentally friendly’ solutions for their data centers, and that aligns with one of our core values here at GRC. It is an honor to be here with the U.S. Ambassador, the Honorable Anthony F. Godfrey to recognize E-Smart Systems and the ZELENDATA CENTRE for their focus on the environment and goal to provide mission critical services to organizations here in Serbia.”

About the ZELENDATA CENTRE

  • 400m2 space
  • 12 ICEraQ Quads. Each Quad includes 4 ICEraQ systems at 25kw per rack.
  • Up to 2 MW substation
  • Uses a Dry Cooler
  • Modular UPS system
  • BISCI and AISI standards

On Wednesday, Peter Poulin attended the ZELENDATA CENTRE grand opening ceremony, along with the Honorable Anthony F. Godfrey, U.S. Ambassador to Serbia; Goran Trivan, Serbia Minister of Environmental Protection; Dragana Mirovic, Mayor of Vršac, Serbia; Goran Veljović, Sales and Marketing Director at E-Smart Systems and 150+ additional stakeholders.

About GRC

GRC is the immersion cooling authority™. The company's patented immersion-cooling technology radically simplifies deployment of data center cooling infrastructure. By eliminating the need for chillers, CRACs, air handlers, humidity controls and other conventional cooling components, enterprises reduce their data center design, build, energy, and maintenance costs. GRC’s solutions are deployed in seventeen countries and are ideal for next-gen applications platforms, including artificial intelligence, blockchain, HPC, 5G, and other Edge Computing and core applications. Their systems are environmentally resilient, sustainable, and space saving, making it possible to deploy the solution in virtually any location with minimal lead time. Visit http://grcooling.com for more information.

About HiTeam

HiTeam was founded in 2003 as part of Hemofarm a.d. The company was the first to bring internet access to Vršac through dial-up and wireless connection, as well as the first internet café in the city. Today the company is 100% owned by E-Smart Systems from Belgrade, with over 90 employees and is the undisputed leader in the regional IT market. Their portfolio of products includes Internet service provider, system support, retail and wholesale hardware and software, and installation of cable systems.

About E-Smart Systems

E-Smart Systems d.o.o. Beograd was founded in 2000 in Belgrade. It is a privately-owned company engaged in development, production, design, implementation and education in the field of information technology. Since 2011, the company has been certified ISO 9001, ISO 27001, and ISO 20000. As one of the first companies in the region using cloud computing, the company offers numerous services to its clients, including information systems safety, financial and industrial systems, IT infrastructure and protection, development and implementation of Microsoft Share Point platform-based solutions, mobile technologies, mobile gateway and embedded systems.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release

Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye